Form 8-K - Current report:
SEC Accession No. 0001659617-19-000077
Filing Date
2019-05-24
Accepted
2019-05-24 16:09:53
Documents
3
Period of Report
2019-05-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kq22019mbrxannualmee.htm 8-K 55679
2 EXHIBIT 3.1 exh31moleculin-charteramen.htm EX-3.1 5215
3 moleculin-logo_horiz.jpg GRAPHIC 132868
  Complete submission text file 0001659617-19-000077.txt   234563
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 19854541
SIC: 2834 Pharmaceutical Preparations